0001062993-24-014086.txt : 20240725
0001062993-24-014086.hdr.sgml : 20240725
20240725163103
ACCESSION NUMBER: 0001062993-24-014086
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240723
FILED AS OF DATE: 20240725
DATE AS OF CHANGE: 20240725
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hippel James
CENTRAL INDEX KEY: 0001603594
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 241142484
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-07-23
0000842023
BIO-TECHNE Corp
TECH
0001603594
Hippel James
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
1
0
0
CFO
0
Common Stock
2024-07-23
4
M
0
35000
31.26
A
107284
D
Common Stock
2024-07-23
4
F
0
24282
77.77
D
83002
D
Stock Options (Right to Buy)
31.26
2024-07-23
4
M
0
35000
0
D
2024-08-09
Common Stock
35000
106867
D
Stock Options (Right to Buy)
44.33
2025-08-08
Common Stock
168620
168620
D
Stock Options (Right to Buy)
47.60
2026-08-07
Common Stock
186068
186068
D
Stock Options (Right to Buy)
66.97
2027-08-05
Common Stock
90740
90740
D
Stock Options (Right to Buy)
66.97
2027-08-05
Common Stock
76588
76588
D
Restricted Stock Units
Common Stock
7780
7780
D
Performance Stock Options (Right to Buy)
120.46
2028-08-06
Common Stock
30400
30400
D
Stock Options (Right to Buy)
120.46
2028-08-06
Common Stock
40536
40536
D
Restricted Stock Units
Common Stock
10912
10912
D
Performance Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
33916
33916
D
Stock Options (Right to Buy)
94.52
2029-08-15
Common Stock
45220
45220
D
Restricted Stock Units
Common Stock
13865
13865
D
Performance Stock Options (Right to Buy)
84.61
2030-08-15
Common Stock
37314
37314
D
Stock Options (Right to Buy)
84.61
2030-08-15
Common Stock
45923
45923
D
Restricted Stock Units
Common Stock
26318
26318
D
The Reporting Person's direct ownership has been increased by 400 shares pursuant to a clerical error in a previous filing.
Fully exercisable.
Options to purchase 19,147 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025.
/s/ Andrew Nick as Attorney-in-Fact for James Hippel pursuant to Power of Attorney previously filed
2024-07-25